RSS Feed
January 9th, 2012 
FAKE NEWS for the Zionist agenda Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
Powerful New Painkillers Could Lead to More
Violent Robberies: Senator
Market approval of new types of “super painkillers” currently under
review by the U.S. Food and Drug Administration could lead to an increase
in violent robberies by people who want to sell the drugs on the streets,
warns U.S. Senator Charles Schumer.
“It’s tremendously concerning that at the same time policymakers and
law enforcement professionals are waging a war on the growing prescription
drug crisis, new super-drugs could well be on their way, flooding the
market,” Schumer, D-N.Y., told the Associated Press. “The FDA needs
to grab the reins and slow down the stampede to introduce these powerful
narcotics.”
Recent violent robberies involving prescription painkillers have left
six people dead. On New Year’s Eve, a robber and a federal agent died
during a robbery at a Long Island pharmacy. Last June, a heist of 11,000
hydrocodone pills at another Long Island pharmacy resulted in four
deaths.
Tests are currently underway on four drugs that contain a more powerful
version of hydrocodone, one of the most abused painkillers in the U.S.,
the AP reported.
If the FDA approves these drugs, Schumer said their needs to be “robust
post-market surveillance” of the drugs as they are marketed, advertised
and sold.
—–
Drug Maker Recalls Bottles of Excedrin, NoDoz,
Bufferin and Gas-X
Certain bottles of the over-the-counter medicines Excedrin, NoDoz,
Bufferin and Gas-X are being recalled because they may contain stray pills
from other medicines, or chipped or broken tablets, Novartis said
Sunday.
The recall includes bottles of Excedrin and NoDoz with expiration dates
of Dec. 20, 2014 or earlier, and packages of Bufferin and Gas-X with
expiration dates of Dec. 20, 2013 or earlier, the Associated Press
reported.
More information is available on the company website and customers can
also call Novartis at 1-888-477-2403 Monday to Friday, 9 a.m. to 8 p.m.
EST.
The recall announcement follows Novartis’ recent decision to
temporarily halt production at its Lincoln, Neb. plant for “maintenance
and other improvement activities,” the AP reported.
—–
Views: 0
Posted in 
Tags: 
